JACQUELINE CELMER: Open Payments
NPI 1811245178 · COUNTRYSIDE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 44 payments from 13 companies in 2025. Trend: 2023 $982 · 2024 $607 · 2025 $872
Food & beverage: $872
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $209 |
| Amgen Inc. | 7 | $138 |
| Lilly USA, LLC | 6 | $109 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Radius Health, Inc. | 4 | $77 |
| Novo Nordisk Inc | 3 | $70 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| PFIZER INC. | 1 | $23 |
Products named: FARXIGA, REXULTI, MOUNJARO, Tymlos, AIRSUPRA, OTEZLA, EVENITY, Ozempic.
Industry payments across IL — which companies pay providers there.
